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Synchronized Coronary Venous Retroperfusion: Prompt Improvement
of Left Ventricular Function in Experimental Myocardial Ischemia
SHIGERU YAMAZAKI, MD, J. KEVIN DRURY, MD, FACC, SAMUEL MEERBAUM, PHD, FACC,
ELIOT CORDAY, MD, FACC
Los Angeles. California
The effect of synchronized coronary venous retroper-
fusion of arterial blood on cardiac function after exper-
imental coronary occlusion was examined by two-
dimensional echocardiography. In 18 closed chest an-
esthetized dogs, the proximal left anterior descending
coronary artery was occluded for 6 hours with an intra-
coronary balloon catheter. Eight of these animals served
as untreated controls. Ten were treated with synchro-
nized retroperfusion initiated 30 minutes after occlusion,
and treatment was interrupted for 5 minutes at 1 hour
after occlusion for study of the rapidity of retroperfusion
response. Quantitative echographic analysisyieldedglobal
ejection fraction and regional indexes of contraction in
a low left ventricular short-axis section, including seg-
mental systolic area change, systolic wall thickening and
end-diastolic wall thickness.
At 6 hours after occlusion, ejection fraction had de-
creased from 50.7 ± 4.9% to 28.1 ± 7.7% (mean ±
standard deviation) in control dogs, but was significantly
Coronary venous retroperfusion was suggested as a possible
mode for treating myocardial ischemia as early as the end
of the 19th century (I). Subsequent retroperfusion studies
concentrated largely on a permanent surgical aortocoronary
venous shunt for retrograde treatment of diffuse coronary
disease in which attempts at reestabli shment of anterograde
coronary artery flow did not appear practical (2- 10). In
recent years , a method of diastolic retroperfusion , using
specially designed catheters and an electrocardiographically
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(p < 0.01) less depressed in treated dogs (from 55.9 ±
5.2 to 41.8 ± 9.3%). The ischemic zone fractional area
change at 30 minutes of occlusion exhibited a marked
depression in both groups, after which the dysfunction
persisted in the control dogs, but was largely reversed
with retroperfusion from 6.0 ± 6.5 to 35.9 ± 15.9% at
6 hours of occlusion (p < 0.01). Brief interruption of
retroperfusion 1 hour after occlusion reduced ischemic
zone fractional area change from 33.0 ± 14.9 to
12.2 ± 9.5% (p < 0.01). This depression was promptly
reversed to 33.6 ± 12.2% when retroperfusion was re-
sumed. SegmentalwallthickeningfoUowed a similar trend.
Compared with previously observed derangements of
sudden reperfusion, retroperfusion did not result in in-
creased diastolic wall thickness in the ischemic zone and
was not associated with arrhythmias. Thus, synchro-
nized retroperfusion rapidly restored regional as well as
global cardiac function during acute coronary occlusion.
(J Am Coil CardioI1985;5:655-63)
synchronized pump, has been shown to significantly im-
prove cardiac function and reduce infarct size after exper-
imental coronary artery occlusion (11-20). This method has
been proposed as a temporary clinical emergency treatment
of acute myocardial ischemia. for example, to provide sup-
port for periods of 6 to 12 hours after an acute coronary
occlu sion . However, the rapidity with which benefits can
be provided during myocardial ischemia has not been well
defined , and more retroperfusion data are required for ex-
tended periods of treatment. The present study was per-
formed in closed chest dogs to determine the extent to which
synchronized retroperfusion can reverse global and regional
left ventricular dysfunction caused by a 6 hour coronary
occlusion , and also to demonstrate the prompt beneficial
response to synchronized retroperfusion .
Methods
Experimental preparation. Twenty-three closed chest
mongrel dogs weighing 24 to 39 kg were anesthetized with
0735-1097/85/$3 .30
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sodium pentobarbital (25 mg/kg intravenously) 30 minutes
after premedication with morphine sulfate (2 mg/kg intra-
muscularly). After intubation, the dogs were placed on a
Harvard respirator connected to an oxygen cylinder with
which ventilation variables were controlled to maintain ar-
terial blood gases (Paz> 100 mm Hg, Pco, < 40 mm Hg).
The pH was maintained at 7.35 to 7.45 by sodium bicar-
bonate. To prevent intracatheter clotting, heparin (10,000
IV) was given intravenously before instrumentation and was
subsequently supplemented to maintain an activated clotting
time of more than 480 seconds. A supplemental dose of
sodium pentobarbital was also administered whenever nec-
essary to maintain a constant state of anesthesia.
A 2F balloon-tipped catheter was introduced under flu-
oroscopic control into the left anterior descending coronary
artery, and the balloon was inflated for coronary occlusion
at a site immediately proximal to the first diagonal branch.
Aortic and left ventricular catheters were introduced through
femoral arteries and connected to Statham P23Db trans-
ducers to measure aortic root and left ventricular pressure,
respectively. Blood pressures and the electrocardiogram were
monitored on a model V12, Electronics for Medicine phys-
iologic recorder. A Swan-Ganz 7F thermodilution catheter
(American Edwards Laboratories) was placed in the pul-
monary artery for cardiac output measurement.
Synchronized retroperfusion system (Fig. 1). In this
series of experiments, a new USCI synchronized retroper-
fusion pump (model EC-I) and catheter (USCI, a division
of C.R. Bard, Inc.) were employed. The autoinflatable
Figure 1. Schematic diagram of experimental synchronized
retroperfusion (SRI')system.The leftanteriordescending coronary
artery (LAD ART.) is occluded by means of an intracoronary
balloon catheter, resulting in regional acute ischemia. Arterial
blood is shunted from the brachial artery into a pump chamber
(inset). The upwardmovement of a piston onto the pump chamber
during diastole propels the arterial blood into the great cardiac
vein. Flow rate is monitored with an electromagnetic (EM) flow-
meter probe. AI = anterior interventricular.
SRP PUMP
balloon-tipped retroperfusion catheter was introduced under
fluoroscopic control through the right internal jugular vein
and advanced through the coronary sinus into the great car-
diac vein. One end of a 7F cannula was inserted into the
brachial artery and its other end was attached to the retro-
perfusion pump inlet. The retroperfusion balloon catheter
was connected to the pump outlet by way of a cannulated
electromagnetic flow probe used to monitor the retroper-
fusion flow rate. After removal of all air bubbles from the
system, arterial blood was shunted through the pump from
the aortic arch to the great cardiac vein, and the pump was
adjusted to maintain a mean retroperfusion flow rate of 60
to 70 ml/rnin, with active flow limited to diastole by electro-
cardiographic synchronization of the pump.
The 7F retroperfusion autoinflatable balloon catheter is
actuated directly from the central lumen of the catheter
through several openings communicating with the balloon.
Thus, during diastole, retroperfusion flow through the cath-
eter lumen automatically inflates the balloon which tem-
porarily obstructs the coronary vein and ensures that the
retroperfusion flow is directed primarily toward the ischemic
region. Conversely, in systole when phasic retroperfusion
is stopped by the synchronized pump, the balloon collapses
rapidly by virtue of its own elasticity and external pressure
differential, allowing physiologic systolic coronary venous
drainage to take place through the coronary sinus into the
right atrium.
Two-dimensional echocardiographic measurements.
Two-dimensional echocardiography was used for serial
measurements of global and regional left ventricular func-
tion. Several short-axis sections arid one long-axis section
of the left ventricle were imaged, and left ventricular vol-
umes as well as ejection fraction were reconstructed using
a modified Simpson's rule (21). For segmental left ventric-
ular function measurements, a low left ventricular short-
axis cross section was subdivided into eight segments, using
it standardized fixed axis with internal referencing system
as previously described (20). A computer-assisted system
was employed to calculate regional left ventricular fractional
area changes, wall thickening and wall thickness from the
entire cross section as well as for each of the eight subseg-
ments. The ischemic segment was defined as the segment
that had the most depressed systolic fractional area change
after coronary occlusion. The nonischemic segment was
defined as the segment diametrically opposite the ischemic
segment.
Experimerital protocol. All dogs underwent proximal
left anterior descending coronary artery occlusion for 6 hours.
The control group had no treatment during the occlusion,
whereas the treated group underwent synchronized retro-
perfusion from 30 minutes after occlusion to the end of the
6 hour occlusion period. Sequential hemodynamic and two-
dimensional echocardiographic measurements were ob-
tained in the baseline preocc1usion state and then at 30, 60
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and 360 minutes after the occlusion. In seven of the treated
dogs, retroperfusion at 1 hour after occlusion (30 minutes
after instituting retroperfusion) was interrupted for 5 minutes
and then reestablished to provide echographic measurements
before, during and shortly after the temporary interruption,
thus characterizing the rate of response to synchronized
retroperfusion. At the end of the study, the dogs were killed.
Gross and microscopic examination of the coronary venous
system was performed in all dogs to detect the damage that
might be induced by the retroperfusion procedure.
Statistical analysis. All data are expressed as mean val-
ues ± standard deviation. Differences were compared using
Student's t test for unpaired data. The level of significance
was set at a probability (p) value of less than 0.05.
Results
Of 23 dogs studied, 4 were excluded because they died
of ventricular fibrillation within 30 minutes of coronary
artery occlusion (before randomization to control or treat-
ment groups). Also excluded from the study was one dog
in which electrocardiographic and echocardiographic ex-
aminations suggested no myocardial ischemia after coronary
occlusion, presumably because of substantial coronary col-
lateralization. Of the remaining 18 dogs, all of which sur-
vived the experimental period of 6 hours, 8 were assigned
to an untreated occlusion control group and 10 to the retro-
perfusion-treated group.
Retroperfusion technique. Synchronized retroperfu-
sion was instituted in all of the experimental animals without
difficulty. The retroperfusion catheter was inserted into the
great cardiac vein in less than 15 minutes, and all the ad-
ditional procedures, including brachial artery cannulation
and connection of inlet and outlet tubing to the retroper-
fusion pump, were completed within 5 minutes. The usual
overall period up to the start of retroperfusion was between
10 and 20 minutes.
Independent pathologic inspection of the coronary sinus
and great cardiac vein after the experiments did not reveal
any significant damage to these vessels. Thus, insertion of
the retroperfusion catheter and repeated balloon inflation
within the great cardiac vein was not associated with sig-
nificant vascular trauma.
Hemodynamics. Table I summarizes the hemodynamic
changes observed in both groups during the 6 hour coronary
artery occlusion. No significant differences were seen be-
tween the control and treated groups in either the preocclu-
sion or 30 minute postocclusion state. After randomized
assignment to control and treatment, the treated dogs ex-
hibited a significantly slower heart rate and a lower left
ventricular end-diastolic pressure at 60 minutes of occlu-
sion. Six hours after occlusion, left ventricular end-diastolic
pressure remained elevated in the control group, but was
significantly lower in the treated group. Retroperfusion tended
to improve cardiac index, stroke volume index and stroke
work index; however, differences between control and treated
groups did not reach statistical significance at 6 hours of
occlusion.
Table 2 shows the hemodynamic data in the treated dogs
at I hour of occlusion (30 minutes of retroperfusion), 5
minutes after interruption and 5 minutes after resumption
of retroperfusion. No significant hemodynamic derangement
was produced by the 5 minute interruption ofretroperfusion.
Two-dimensional echocardiographic data. Figure 2
illustrates the time course of echocardiographic cross-
sectional and segmental systolic fractional area changes
measured in a low left ventricular short-axis cross section
in representative control and retroperfusion-treated dogs.
The uniform inward wall motion before coronary occlusion
indicates normal left ventricular contraction in both dogs.
Table 1. Hemodynamic Measurements
60 Minute 0 6 Hour 0
Pre 0 30 Minute 0 (30 minute SRP) (5\1, hour SRP)
HR CTR 102 ± 27 139 ± 13 143 ± 21 155 ± 48
(beats/min) SRP 98 ± 36 119 ± 26 119 ± 20" 130 ± 19
MAP CTR 113 ± 22 108 ± 30 116 ± 24 95 ± 25
(mmHg) SRP 109 ± 10 100 ± 20 102 ± 16 104 ± 22
LVEDP CTR 3.1 ± 1.4 8.6 ± 3.6 7.4 ± 4.3 8.4 ± 2.3
(mm Hg) SRP 3.7 ± 1.2 5.7 ± 2.7 3.8 ± 2.4" 4.7 ± 3.2"
CI CTR 2.1 ± 0.4 2.6 ± 0.7 2.2 ± 0.8 1.4 ± 0.3
(liters/min per rrr') SRP 2.2 ± 0.5 2.1 ± 0.8 2.1 ± 0.7 1.8 ± 0.8
SVI CTR 22 ± 8 19 ± 5 16 ± 8 10 ± 4
(ml/beat per m2) SRP 24 ± 8 20 ± 8 20 ± 18 13 ± 6
SWI CTR 37 ± 16 28 ± 12 25 ± II 13 ± 8
(g/beat per nr') SRP 36 ± 9 28 ± 14 28 ± 14 20 ± 12
*p < 0.05 versus control. Values are mean ± standard deviation. CI = cardiac index; CTR = control
series; HR = heart rate; LVEDP = left ventricularend-diastolicpressure; MAP = mean aortic pressure; 0 =
left anterior descending coronary artery occlusion; SRP = synchronized retroperfusion; SVI = stroke volume
index; SWI = stroke work index.
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Table 2. Hemodynamics During Synchronized Retroperfusion On-Off-On Cycling
30 Minute SRP SRP Off 5 Minutes SRP On 5 Minutes
(60 minute 0 ) (65 minute 0 ) (70 minute 0 )
HR 119 ± 20 115 ± 20 109 ± 20
(beats/min)
MAP 102 ± 16 104 ± 16 III ± 15
(mm Hg)
LVEDP 2.6 ± 1.9 2.4 ± 1.0 2. 1 ± 1.6
(mm Hg)
CI 2.1 ± 0.7 2.0 ± 0.8 2.1 ± 0.4
(liters/min per rrr' )
SVI 20 ± 18 18 ± 9 20 ± 5
(ml/beat per m2)
SWI 28 ± 14 29 ± 15 32 ± 12
(g/beat per m2)
Values are mean ± standard deviation. Abbreviations as in Table I.
Measurements at 30 minutes of occlusion in both dogs reveal
a clearly defined region of severe dysfunction, encompass-
ing segments corresponding to the risk area subserved from
the occluded coronary artery . In the control dog , this dys-
function remained substantially unaltered over the 6 hour
occlusion period . In contrast, the treated dog (5 112 hours
after retroperfusion) exhibited a significant improvement in
contraction .
Alterations in left ventricular end-diastolic volume and
ejec tion fra ction are shown in Figure 3 . The end-diastolic
volume was plotted as percent change from its preocclusion
value because of large variation s in the size of the dogs'
ventricles. Thirty minutes after coronary occlusion , both
groups exhibited an equi valently increased end-diastolic
volume and reduced ejection fraction. Thereafter, with ret-
roperfu sion treatment, end-diastolic volume was reduced
toward the preocclusion levels and ejection fraction was
restored, whereas in the control dogs the increased end-
diastolic volume persisted and ejection fraction decreased
further between 30 minutes and 6 hours of occlusion. Dif-
ferences between control and treated dogs were significant
(p < 0.0 I) in both of these global indexes 6 hours after
coronary occlusion.
Sequential echographic measurements of ischemic zone
systolic fractional area change and wall thickening are dem-
onstrated in Figure 4. Both group s exhibited a markedly
depre ssed fractional area change at 30 minutes postocclu-
sion. This depressed regional dysfunction persisted through
the 6 hour occlusion period in the control dogs , but in the
treated dogs, ischemic zone function was essentially re-
stored after the start of the retroperfusion treatment. Yet
function did not return completely to the preocclusion level
at the end of the 6 hour occlu sion . Similarly , ischemic zone
left ventricular systolic wall thickening was significantly
decreased at 30 minute s of occlusion in both groups . It
improved significantly with retroperfusion treatment and re-
mained depressed in the control dogs at 6 hours of occlusion .
Systolic fractional area change and wall thickening in theSRPCONTROL
6 hr OCCLUSION
EOA=9.7cm· ESA=8.1 FAC=16.3'" EOA=7.4cm· ESA=4.2 FAC=43.3'llo
30 min OCCLUSION
EOA= 9.3cm· ESA = 7.3 FAC = 21.8" EOA = 10.gem' ESA = 8.2 FAC = 25.0'11.
PRE-OCCLUSION
EOA28.8e~ ESA=5.1 FAC=42.1" EOA=8.3em' ESA=4.5 FAC=45.5"
Figure 2. Two-dimensional echocardiographic computer-assisted
segmental wall motion analysis of endocardial outlines in a low
left ventricular level cross section . Left ventricular endocardium
is indicated with continuous lines at end-diastole and with dashed
lines at end-systole (stippled area). Systolic fractional area change
(FAC) was calculated for the entire cross section as well as for
individual segments (I to 8) according to the formula: FAC =
(EDA - ESA)/EDA X 100. where EDA = end-diastolic area
and ESA = end-systolic area. In this view. the interventricular
septum is on the left and top and the anterior wall at the bottom.
SRP = synchronized retroperfu sion .
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Figure 4. Top chart illustrates segmenta l systolic fractional area
change (FAC) of the ischemic zone at the low left ventricular level
measured by two-dimensional echocardiography in untreated and
synchronized retroperfusion-treated (SRP) dogs. Bottom chart
shows ischemic zone segmental systolic wall thickening (W-Th)
at the low left ventricular level in control and treated dogs. 0
left anterior descending coronary artery occlusion.
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Figure 3. Top chart illustrates the percent change in left ven-
tricular end-diastolic volume (LVEDV) from preocclusion control
values measured by two-dimensional echocardiography in un-
treated and synchronized retroperfusion-(SRP) treated dogs (mean
± standard deviat ion). Bottom chart represents left ventricular
ejection fraction (LVEF) reconstructed from several short-axis and
long-axis echocardiographic cross sections in untreated and retro-
perfusion-treated dogs . 0 = left anterior descending coronary
artery occlusion.
non ischemic zone were not affected by ei the r occlus ion or
retroperfusion (Table 3). Alterat ion s in left ventricular end-
d iastol ic wa ll thic kness measurements are shown in Tabl e
4. In the ischemic zo ne. end- diastolic wall th ickness was
first reduced by coronary occlusion, wh ich also increased
chamber vo lume. Wall thickness tended to be restored with
retroperfu sion treatment. a lthough differences between the
groups we re not significa nt, possibly becau se of large stand-
ard deviations in ec hocardiographic thickness measurements.
Figure 5 illustrates the effects of temporary interr uption
of retroperfusion at I hour of coronary occlusion (30 min-
Table 3. Two-Dimensional Echographic Measurements of Nonischemic Regional Function
60 Minute 0 6 Huur 0
Pre 0 30 Minute 0 (30 minute SRP) (5 '/2 hour SRPj
'HAC
CTR 48. 1 ± 5.7 43.6 ± 4.4 46.2 ± 11.5 43 .1 :!: 6.3
SRP 50. 1 ± 8.2 49.4 :!: 9.6 42.9 :!: 9 .8 42.7 ± 9.9
%W-Th
CTR 31.3 :!: 6.6 30.4 :!: 5.0 32.4 :!: 6.9 28.9 :!: 5.1
SRP 32.0 ± 4.2 27.7 ± 4.8 24.4 ± 5.9 24.6 ± 5.8
Values are mean :!: standard deviation. FAC = systolic fractional area change : W-Th = systolic wall
thickening; other abbreviations as before.
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Table 4. Echographic Measurements of End-Diastolic Wall Thickness (mm)
Pre a 30 Minute a 1 Hour a 6 Hour a
Ischemic zone
CTR
SRP
Nonischemic zone
CTR
SRP
7.8 ± 0.7
7.9 ± 1.3
7.7 ± 0.9
7.9 ± 1.3
7.4 ± 0.7
7.4 ± 1.1
7.7 ± 0.8
7.9 ± 1.3
7.3 ± 0.8
7.9 ± 1.3
7.6 ± 0.8
7.8 ± 1.6
7.3 ± 0.5
7.6 ± 1.5
7.6 ± 0.8
7.8 ± 1.5
Values are mean ± standard deviation. Abbreviations as before.
Figure 5. Segmental wall motion analysis of short-axis endocar-
dial outlines at the low left ventricular level. showing the rapid
effect of synchronized retroperfusion (SRP). Continuous lines
and dashed lines indicate left ventricular endocardium at end-
diastole and end-systole, respectively. Analysis was performed
before (upper right ) and after (lower left) a 5 minute interruption
of retroperfusion and 5 minutesafter resumptionof retroperfusion
(lower right) . EDA = end-diastolic area; ESA = end-systolic
area; FAC = systolic fractional area change.
PRE-OCCLUSION 60 min LAD OCCLUSION
(30 min SRP)
EOA=8.3cm' ESA=4.5 FAC=45.5% EOA=10.5cm' ESA=5.9 FAC=43.4%
utes ofretroperfusion}. Interruption of the treatment resulted
in a rapid and major reduction in sectional and ischemic
segment fractional area change, which was then quickly
restored with resumption of retroperfusion. Table 5 lists the
prompt effects of retroperfusion on left ventricular function.
Left ventricular ejection fraction was slightly but not sig-
nificantly reduced by the 5 minute interruption of retroper-
fusion , but regional ischemic zone fractional area change
was significantly decreased 5 minute s after the interruption
and was restored 5 minutes after resumption of the retro-
perfusion treatment (Fig. 6). Left ventricular systolic wall
thickening during the on-off-on retroperfusion procedure
followed the same course as fractional area change.
Discussion
Previous studies. Various techniques for protecting
acutely ischemic myocardium have been proposed and in-
vestigated in animal studies and , more recently, in patients
with evolving myocardial infarction (22-26). Medical and
surgical management are basically aimed at increasing the
jeopardized myocardial oxygen supply to demand ratio . The
most fundamental approach to preservation of myocardial
cells is, of course, to restore their supply of oxygen and
substrates by reestablishing normal circulation of arterial
blood to the vascular bed that had been obstructed . Clinical
and experimental observations (27-31) have demonstrated
that coronary artery reperfusion , provided promptly within
the first hours from the onset of a coronary occlusion, may
be capable of improving ischemic zone cardiac function and
myocardial metabolism as well as reducing infarct size and
increa sing survival. Howe ver , the earliest stage of reper-
fusion is known to be often associated with deleterious ar-
rhythmias, myocardial hemorrhages and hemodynamic,
metabolic and significant functional derangements ("no re-
flow" phenomena) that tend to persist for appreciable pe-
riods (32-37). Several studies (38,39) demonstrated that
irreversible myocardial tissue damage in dogs begins as
early as 30 to 40 minutes after an acute coronary artery
occlusion . The time interval from an acute coronary occlu-
sion to restoration of "adequate" (not well defined) coro-
nary flow is clearly one of the major factors and potential
limitations of any reperfusion treatment , because even com-
plete resumption of perfusion may be of little benefit or
injurious after myocardium or microvasculature become se-
verely damaged.
In view of the need for a temporary and simple emergency
treatment for maintaining viability and function of acutely
ischemic and anterogradely poorly accessible myocardium,
coronary venous retroperfusion has been proposed as a cir-
culatory support that can be applied before specific surgical
or nonsurgical reperfusion interventions. Previous experi -
mental studies have already demonstrated that selective (great
cardiac vein) retroperfusion delivers arterial blood to the
ischemic capillary network subserved from the left anterior
descending coronary artery (I I , 15, 17,40), and that arterial
blood retroperfusion is capable of maintaining the function
70 min LAD OCCLUSION
(SRP-ON 5min)
EDA=6.1cm' ESA=4.2 FAC=48.8%
e
65 min LAD OCCLUSION
(SRP-OFF 5min)
EOA=9.5cm' ESA=6.6 FAC=31.0%
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Table 5. Global and Segmental Response to Synchronized Retroperfusion On-Off-On Cycling
30 Minute SRP SRP Off 5 Minutes SRP On 5 Minutes
(60 minute 0) (65 minute 0) (70 minute 0)
LVEF 41.1 ± 7.0 35.9 ± 8.6 42.2 ± 8.4
%FAC
I zone 33.0 ± 14.9 12.2 ± 9.5* 33.6 ± 12.2t
NI zone 42.0 ± I\.I 46.0 ± 13.3 39.7 ± 13.4
%W-Th
I zone 25.1 ± 8.0 9.6 ± 5.5* 24.3 ± 8.6t
NI zone 25.4 ± 6.4 27.4 ± 7.5 3\.4 ± 7.9
*p < 0.01, 30 minute SRP versus SRP Off 5 minutes; tp < 0.01, SRP Off 5 minutes versus SRP On 5
minutes. Values are mean ± standard deviation. I = ischemic; NI = nonischemic; other abbreviations as
before.
Figure 6. Systolic fractional area change (FAC) in the ischemic
segment of the left ventricle during synchronized retroperfusion
(SRP) on-off-on cycling (mean ± standard deviation). Note that
at 1 hour coronary occlusion (0) with 30 minutes of retroperfusion,
systolic fractional area change was increased by the treatment to
near control levels (see Fig. 4). At I hour postocclusion, syn-
chronized retroperfusion was interrupted for 5 minutes. Two-
dimensional echographic measurements were obtained 5 minutes
after interruption as well as 5 minutes after resumption of retro-
perfusion. It is seen that the retroperfusion-induced improvement
of segmental function was highly significant and rapid.
and viability of acutely ischemic myocardium (11,12,
16,17,19).
Effects of synchronized retroperfusion. In this study,
hemodynamic and echocardiographic measurements re-
vealed that arterial blood retroperfusion, applied from 30
minutes after coronary occlusion through a maintained 6
hour occlusion, provides significant improvements in both
global and regional left ventricular function. Two-dimen-
sional echographic measurements demonstrated that re-
gional systolic fractional area change in the center of the
ischemic zone was markedly improved through application
of retroperfusion. Function of the nonischemic zone did not
change substantially in either the control or the treated group.
In line with prior impressions of prompt effects of retro-
perfusion, our experimental data corroborated that arterial
blood retroperfusion through the great cardiac vein during
the reversible stage of left anterior descending coronary
artery occlusion improved left ventricular systolic function
very rapidly, even in the most profoundly affected ischemic
zone. Although our temporary on-off-on procedure was per-
formed at a preselected time (1 hour of occlusion with 30
minutes of retroperfusion) and similar studies are needed
for evaluation of later periods of ischemic injury, it appears
that synchronized retroperfusion may serve as a prompt
emergency tteatment of rapidly evolving acute myocardial
infarction.
Advantages of synchronized retroperfusion. With our
synchronized retroperfusion system, retrograde perfusion is
limited to the diastolic period and is propelled into the coro-
nary vein when its venous blood drainage and venous pres-
sure are at a minimum, thus favoring maximal retroinfusion
into the ischemic area. Retroperfusion is discontinued and
the coronary venous catheter balloon is automatically de-
flated during systole, allowing physiologic coronary venous
drainage through the coronary sinus into the right atrium.
Several investigators (2-10) found that complete or partial
ligation of the coronary sinus may provide sufficient ret-
rograde flow to the ischemic myocardium, but that when
this ligation was maintained, it caused vascular congestion
(despite the existing coronary venous shunting), often lead-
ing to myocardial hemorrhages, fibrosis and congestive fail-
ure (41). It has been observed (42) that a retroperfusion
mean coronary venous pressure in excess of 40 mm Hg may
cause ecchymosis, and a pressure of 80 mm Hg induces
significant damage to the coronary venous system. In our
studies with retroperfusion flows of 60 to 70 mllmin, re-
gional mean coronary venous pressure was less than 30 mm
Hg, and no significant damage or injury was observed
(11,17,43). Moreover, direct postmortem inspection of the
coronary sinus and great cardiac vein did not reveal any
evidence of superficial or intimal damage to these vessels,
either from insertion of the retroperfusion catheter or from
the 51/ 2 hours of synchronized balloon inflation within the
coronary vein. Thus, coronary venous drainage is of great
~p<O.Ol----.
~p<O.Ol-----.
60 min OCCLUSION 65 min 0 70 min 0
(30 min SRP) (SRP-OFF 5 min) (SRP-ON 5 min)
10
50
40
20
o
~ 30
?f.
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importance in view of potential vascular and myocardial
damage . Howe ver , another reason for facilitating draina ge
is to avoid excessi ve toxic metabolite accumulations and
acidosis within the ischemic myocardium. The latter may
inhibit glycoly sis and further reduce the period of viabilit y
of the jeopardized myocardium (44-46).
The end-diastolic wall thickness in the ischemic region
was decreased after coronary occlusion , presumabl y because
of expansion of the left ventricul ar chamber and the initial
decrea se of ischemi c zone wall tension. During the retro-
perfusion treatment , wall thickne ss was found to approach
but not exceed the preocclusion value. We also performed
supplemental measurements of myocardial water content,
which suggested that synchronized retroperfusion did not
induce tissue edema, a factor often associated with elevated
coron ary venous pressures and frequently observed early
after sudden anterograde reperfusion . Measurements of in-
farct size after 6 hours of occlu sion verified previous retro-
perfusion data on ischem ic myocardial tissue viabilit y, and
are reported elsewhere (43) in conjunction with observations
indicating the safety of the method as well as the lack of
significant damage to formed blood clements. In our study,
synchronized retroperfusion was not associated with dele-
terious arrhythmias, which are frequentl y encountered after
sudden anterograde reperfu sion, possibly because of sudden
washout of electrolytes. We belie ve that arrhythmias were
absent becau se of the more gradual and partial character of
the retroperfusion-induced augmentation of ischemic zone
perfusion . From our experience , the time for introduction
of coronary venous catheterization and initiation of the ret-
roperfusion treatment was always less than 20 minutes ,
indicating favorable logistics of the retroperfusion technique.
Implications of study. The results of this and previous
studie s suggest that synchronized retroperfusion, when in-
itiated early after coronary occlusion, can rapidly and sig-
nificantl y improve cardiac function durin g a 6 hour period
of maintained coronary occlu sion. Coronary venous cath-
eterization can be performed easily and quickly, which is
esse ntial to prevent the rapidl y evol ving myocardial necro-
sis. Another benefit of this treatment is related to the manner
in which perfusion in the jeopardized zone is enhanced
without inducing arrhythmias or significantly extended car-
diac dysfunction (stunned myocardium), both of which are
often encountered with anterograde sudden reperfusion. The
rapid recovery of function with retroperfusion facilitates the
use of a relati vely simple on-off-on procedure to evaluate
the effectiveness of the treatment. Synchronized retroper-
fusion may be applied to provid e an effect ive temporary
support to acutely ischemic myocard ium pending more de-
finitive therapy such as thrombolysis, percutaneous trans-
luminal coronary angioplasty or emergency coronary artery
bypas s graft surgery. However , before widespread clinical
applic ation, controlled clinical studies must be performed
to determine the efficacy of the technique in human subjects.
We thank Myles Prevost and Moses Sabado for techn ical assistance. Jiirate
Krosniiinas Sutor for manuscript preparation and Jeanne Bloom for help
in editing the manuscript.
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